Cargando…

The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression

Chemoresistance hinders the curative cancer chemotherapy. To define the role of the DNA methylation-regulated microRNA (miR) genes in the chemoresistance of bladder cancer, we performed both DNA methylomic and miRomic analyses of a multi-chemosensitive (5637) versus a multi-chemoresistant (H-bc) cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, L, Deng, H, Li, Y, Zhang, C, Liu, X, Liu, Q, Zhang, D, Wang, L, Pu, Y, Zhang, H, He, Y, Wang, Y, Yu, Y, Yu, T, Zhu, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540198/ https://www.ncbi.nlm.nih.gov/pubmed/25188512 http://dx.doi.org/10.1038/cddis.2014.367

Ejemplares similares

MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2
por: Wang, Haiyan, et al.
Publicado: (2019)

MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression
por: Lin, Maosong, et al.
Publicado: (2019)

SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates
por: Shanmugam, Raghuvaran, et al.
Publicado: (2018)

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
por: Jacques, Camille, et al.
Publicado: (2016)

Functional Validation of the Putative Oncogenic Activity of PLAU
por: Sarno, Federica, et al.
Publicado: (2022)

LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM
por: Zhang, Feifei, et al.
Publicado: (2021)

HIC1 Represses Atoh1 Transcription and Hair Cell Differentiation in the Cochlea
por: Abdul-Aziz, Dunia, et al.
Publicado: (2021)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Chrysin, which targets PLAU, protects PC12 cells from OGD/R-stimulated damage through repressing the NF-κB signaling pathway
por: Li, Ning, et al.
Publicado: (2022)

Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin
por: Yan, B-x, et al.
Publicado: (2014)

Overexpressed PLAU and its potential prognostic value in head and neck squamous cell carcinoma
por: Li, Zhexuan, et al.
Publicado: (2021)

PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC
por: Guo, Zhi-chen, et al.
Publicado: (2023)

FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
por: Ai, Chao, et al.
Publicado: (2020)

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
por: Belisario, Dimas Carolina, et al.
Publicado: (2020)

Prognostic Significance and Gene Co-Expression Network of PLAU and PLAUR in Gliomas
por: Li, Junhong, et al.
Publicado: (2022)

The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes
por: Hayward, Catherine P. M., et al.
Publicado: (2017)

Implication of transcriptional repression in compound C-induced apoptosis in cancer cells
por: Dai, R Y, et al.
Publicado: (2013)

miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2
por: An, Y, et al.
Publicado: (2015)

Hyperglycemia Promotes Endothelial Cell Senescence through AQR/PLAU Signaling Axis
por: Wan, Yiqi, et al.
Publicado: (2022)

miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway
por: Kong, Lingsuo, et al.
Publicado: (2019)

SRSF2 is required for mRNA splicing during spermatogenesis
por: Lei, Wen-Long, et al.
Publicado: (2023)

The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
por: Wang, Hao, et al.
Publicado: (2018)

Does high and intensive care reduce coercion? Association of HIC model fidelity to seclusion use in the Netherlands
por: Van Melle, A. L., et al.
Publicado: (2020)

Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
por: Wu, Wenyi, et al.
Publicado: (2016)

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
por: Hosen, S. M. Zahid, et al.
Publicado: (2022)

The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer
por: Li, Yang, et al.
Publicado: (2015)

MiRNA-210 modulates a nickel-induced cellular energy metabolism shift by repressing the iron–sulfur cluster assembly proteins ISCU1/2 in Neuro-2a cells
por: He, M, et al.
Publicado: (2014)

GLIPR1 Protects Against Cigarette Smoke-Induced Airway Inflammation via PLAU/EGFR Signaling
por: Peng, Wenjun, et al.
Publicado: (2021)

Plau and Tgfbr3 are YAP-regulated genes that promote keratinocyte proliferation
por: Corley, Susan M., et al.
Publicado: (2018)

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
por: Yamasaki, M, et al.
Publicado: (2011)

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
por: Aujla, Amandeep, et al.
Publicado: (2018)

High and Intensive Care in Psychiatry: Validating the HIC Monitor as a Tool for Assessing the Quality of Psychiatric Intensive Care Units
por: van Melle, A. L., et al.
Publicado: (2018)

Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU)
por: Wang, Yanyan, et al.
Publicado: (2021)

‘What puts the ‘Hic’ into Hiccups?’
por: Seifi, Ali, et al.
Publicado: (2022)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma
por: Wu, Min, et al.
Publicado: (2022)

AB068. The splicing factor SRSF1 expression in human bladder carcinoma cells
por: Wang, Ping, et al.
Publicado: (2016)

Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis
por: Zhu, Zhixiang, et al.
Publicado: (2020)

Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
por: Yang, Ke, et al.
Publicado: (2019)

High spin states in $^{189,191,193}$Au
por: Gono, Y, et al.
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_tglump5snoaepbj7t37t9g07ve